Trade Mark Journal No.2025/052 26 December 2025
WO0000001878029 (42)
Office of origin: United States of America
Date of International Registration:23 April 2025
Date of designation in the UK:
23 April 2025
International priority date claimed: 23 October 2024
(United States of America)
(98817414)
- Class 42
- Providing (Saas) software as a service or web-based software to share project level clinical research data and project status with clients; clinical trial site selection and trial site services; clinical trial central lab services; clinical research and scientific analysis in the field of pharmaceutical drugs, medical devices, and clinical trials; clinical trial consulting services; clinical trial cGMP manufacturing services; clinical trial supply services; clinical trial management services; clinical trial laboratory and analytical services; clinical research services; product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development and technological consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays; proving information technology service and technical data analysis in the field of real-world data and real-world evidence.
Thermo Fisher Scientific Inc.
Representative: HGF Limited, 4th Floor, 1 City Square Leeds LS1 2AL UNITED KINGDOM